Are you Dr. Reiman?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 61 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
925 E Mcdowell Rd
4th Floor
Phoenix, AZ 85006Phone+1 602-239-6800Fax+1 602-239-6988- Is this information wrong?
Summary
- Dr. Eric Reiman, MD is a board certified psychiatrist in Phoenix, Arizona. He is currently licensed to practice medicine in Arizona.
Education & Training
- Washington University/B-JH/SLCH ConsortiumResidency, Psychiatry, 1983 - 1983
- Duke University HospitalResidency, Psychiatry, 1980 - 1983
- Duke University School of MedicineClass of 1980
Certifications & Licensure
- AZ State Medical License 1988 - 2026
- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- Clinical Evaluation of Florbetapir F 18 (18F-AV-45) Start of enrollment: 2009 Dec 01
Publications & Presentations
PubMed
- Examination of parkinsonism in former elite American football players.Michael L Alosco, Charles H Adler, David W Dodick, Yorghos Tripodis, Laura J Balcer, Charles Bernick, Sarah J Banks, William B Barr, Jennifer V Wethe, Joseph N Palmisa...> ;Parkinsonism & Related Disorders. 2024 Mar 1
- Longitudinal changes in surface based brain morphometry measures in amnestic mild cognitive impairment and Alzheimer's Disease.Tobias Bachmann, Matthias L Schroeter, Kewei Chen, Eric M Reiman, Christopher M Weise> ;Neuroimage. Clinical. 2023 Jan 1
- 5 citationsMolecular imaging of the association between serotonin degeneration and beta-amyloid deposition in mild cognitive impairment.Gwenn S Smith, Hillary Protas, Hiroto Kuwabara, Alena Savonenko, Najlla Nassery, Neda F Gould, Michael Kraut, Dimitri Avramopoulos, Daniel Holt, Robert F Dannals, Ayon...> ;Neuroimage. Clinical. 2023 Jan 1
- Join now to see all
Press Mentions
- Mutation Protected Man from Alzheimer’s Disease, Hinting at TreatmentMay 15th, 2023
- New Dementia Miracle Drug Hailed as ‘Beginning of End of Alzheimer’s’May 3rd, 2023
- Lilly Drug Slows Alzheimer’s Progression by 35 Per Cent in TrialMay 3rd, 2023
- Join now to see all
Grant Support
- PET, APOE &The Preclinical Course Of Alzheimer'S DiseaseNational Institute On Aging2008–2012
- Neuropathology CoreNational Institute On Aging2011
- Education And Information Transfer CoreNational Institute On Aging2011
- Data Management And Statistics CoreNational Institute On Aging2011
- Clinical CoreNational Institute On Aging2011
- Administrative CoreNational Institute On Aging2011
- Arizona Alzheimer'S Disease Core CenterNational Institute On Aging2001–2011
- The GE Pettrace Cyclotron: A Scientific Resource For The State Of ArizonaNational Center For Research Resources2010
- Cyclotron, PET And MRI Facility Improvement: A Scientific Resource For ArizonaNational Center For Research Resources2010
- PET, APOE &The Preclinical Course Of Alzheimer DiseaseNational Institute Of Mental Health2003–2006
- PET, APOE, &The Preclinical Course Of Alzheimer DiseaseNational Institute Of Mental Health1998–2002
- Application Of PET To The Study Of Psychiatric DisordersNational Institute Of Mental Health1985–1988